Thursday, December 13, 2007 | |
| 05:00 pm | Opening CeremonyChairs : P. Miotti, F. Dabis |
| Welcome addresses
J.E. Touze, Directeur de l’Ecole d’Application des Armées du Val de Grâce E. Menu, G. Scarlatti, D. Béquet, chairs of the conference | |
| 05:15 pm | Introductory lecture Great challenges to PMTCT in the South : The role of the developped nations in supporting strategies that work D.Onyango (KN) |
| 05:45 pm | Session 1a : Viral and maternal determinants of mother to child transmission (MTCT) of chronic viral infectionsChairs : A. Ayouba, C. Davrinche |
| Keynote Lecture : Virologic and host determinants of breastfeeding transmission of human retroviruses P. Van de Perre (F) | |
| 6:15-7:15 pm | |
| 6:15 pm | Primary HIV-1 infection during pregnancy : high rate of HIV-1 MTCT in a cohort of patients in southern Brazil |
| Nielsen-Saines K., Melo M., Varella I., Fonseca R., Lira R., Turella M.L., Canti I., Campello C., Moreira A.M., Riegel Santos B | |
| 6:30 pm | Role of R5 phenotypic variation in mother-to-child transmission of HIV-1 |
| Cavarelli M., Karlsson I., Zanchetta M., Antonsson L., Plebani A., Giaquinto C., Fenyo E.M., De Rossi A., Scarlatti G. | |
| 6:45 pm | Bile-salt stimulated lipase in human milk binds DC-SIGN and inhibits HIV-1 transmission |
| Stax M., Naarding M., Speijer D., Hernell O., Pollakis G., Paxton W. | |
| 7:00 pm | Human herpesvirus 8 (HHV-8) " in vitro" infection of human placental histocultures |
| Di Stefano M., Menu E., Gesualdo L., Greco P., Chieco-Bianchi L., Barbierato M., Cantatore S., di Gangi I.M., Calabre M.L., Fiore J.R. | |
| 7:15 pm | HIV-1 internalization in polarized human trophoblasts occurs through a peculiar endocytic pathway |
| Tremblay M.J., Vidricaire G. | |
| 7:30 pm | WELCOME RECEPTION |
Friday, December 14, 2007 | |
| 09:00 am | Session 1b : Viral and maternal determinants of mother to child transmission (MTCT) of chronic viral infectionsChairs : G. Biberfeld, G. Chaouat |
| Keynote Lecture : Determinants of maternal infection associated with virus infection of the fetus and newborn infant
W. Britt (USA) | |
| 09:00-10:30 am | |
| 9:30 am | A major susceptibility locus for HTLV-1 infection in childhood maps to chromosome 6q27 |
| Plancoulaine S., Gessain A., Tortevoye P., Boland-Auge A., Vasilescu A., Matsuda F., Abel L. | |
| 9:45 am | Influence of pregnancy on the specificity and breadth of antigen recognition by HIV-specific cytotoxic T lymphocytes |
| Jolette E., Samson J., Lapointe N., Boucher M., Soudeyns H. | |
| 10:00 am | HCV-Specific T-cell Responses during Acute Hepatitis C Virus Infection in Pregnancy |
| Honegger J., Prasad M., Colombo D., Bowen D., Walker C. | |
| 10:15 am | Toxoplasmosis reactivation following HAART introduction associated with foetal death in a severely immune suppressed HIV-infected woman : An Immune reconstitution inflammatory syndrome (IRIS) consequence ? |
| Caby F., Lemercier D., Touafek L., Paris L., Gonzalez M., Carcelain G., Pauchard M., Canestri A., Dommergues M., Tubiana R. | |
| 10:30-11:00 am | Coffee break and poster viewing |
| 11:00am | Session 2 : Role of co-infections in MTCTChairs : L. Pembrey, P. Msellati |
| Keynote Lecture : Mechanisms by which co-infections modify HIV-1 transmission G. John-Stewart (USA) | |
| 11:30 am-12:45 pm | |
| 11:30 am | High prevalence of cytomegalovirus (CMV) infection in infants born to HIV infected mothers–ANRS French Perinatal Cohort (EPF) |
| Guibert G., Leruez-Ville M., Rouzioux C., Tubiana R., Mandelbrot L., Blanche S., Teglas J.P., BenMebarek Y., Le Chenadec J., Warszawski J., ANRS French Perinatal Cohort (EPF) | |
| 11:45 am | Hepatitis C virus quasispecies evolution during pregnancy and between consecutive pregnancies : influence of maternal immune responses |
| Troesch M., Meunier I., Lepage C., Samson J., Lapointe N., Boucher M., Soudeyns H. | |
| 12:00 pm | Risk factors for Human Cytomegalovirus (HCMV) infection in infants born to HIV-1 infected mothers in Thailand |
| Khamduang W., Sirirungsi W., Lallemant M., Ardong W., Hinjiranandana T., Sirinontakan S., Somsamai R., Pagdi K., McIntosh K., Leurent B., Jourdain G., Ngo-Giang-Huong N. | |
| 12:15 pm | Co-infection with Trypanosoma cruzi (Chagas´ disease agent) decreases HIV-1 transcription in human placenta. |
| Dolcini G., Solana M.E., Andreani G., Celentano A.M., Donato A.M., Del Rio A., Martinez Peralta L. | |
| 12:30 pm | Plasmodium falciparum and placental cytokine profiles among pregnant women in relation to their HIV-1 status : possible implications for mother-to-child transmission (MTCT) of HIV-1 in Cameroon |
| Kfutwah A., Mary J.Y., Lemen B., Leke R., Rousset D., Barré-Sinoussi F., Nerrienet E., Menu E., Ayouba A. for The ANRS 1267 Study Team | |
| 12:45-2:00 pm | Lunch and posters viewing |
| 2:00 pm | Session 3 : Prevention and control of MTCT : from antivirals through immunotherapy and vaccineChairs : M. Marthas, D.K. Ekouevi |
| Keynote Lecture : Mother-to-Child Transmission of Persistent Viral Infections : Pathogenesis and Prevention
K. Luzuriaga (USA) | |
| 02:30 - 4:00 pm | |
| 2:30 pm | VSV/MVA vaccine rapidly elicits SIV antibodies and local & systemic SIV T cell responses in macaque neonates but does not prevent SIV dissemination after oral challenge |
| Abel K., Van Rompay K.K., Eastlick J., Moore J., Lemieux M., Schmidt K., Earl P., Buonocore-Buzzelli L., Moss B., Rose N., Rose J., McChesney M.B., Kozlowski P., Marthas M.L. | |
| 2:45 pm | Prevention of mother-to-child HIV transmission in France : is access to care different for women from sub-Saharan Africa than for French women ? |
| Jasseron C., Warszawski J., Blanche S., Rouzioux C., Le Chenadec J., Dolfus C., Faye A., Hamrene K., Teglas J.P., Tubiana R., Mandelbrot L., ANRS French Perinatal Cohort (EPF) | |
| 3:00 pm | Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating infants or mothers prophylactically with antiretrovirals in Dar es Salaam, Tanzania. The MITRA and MITRA PLUS studies |
| Kilewo C., Mhalu F., Swai A., Msemo G., Lipyoga R., Lyamuya E., Massawe A., Ngarina M., Karlsson K., Biberfeld G. | |
| 3:15 pm | Prevalence of HIV-1 drug resistance mutations in antiretroviral naïve pregnant women from Cambodia, Cameroon, Central African Republic and Vietnam |
| Ayouba A., for the FSP/RAI/ARV Study Team | |
| 3:30 pm | Low birth weight is associated with maternal Nevirapine based antiretroviral therapy in Abidjan, Côte d’Ivoire : The Ditrame Plus project and MTCT-Plus initiative (2001-2007) |
| Ekouevi D., Coffie P. | |
| 3:45 pm | Tolerance and Viral Resistance After Short Course of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine (FTC) to Prevent Mother-to-Child Transmission (PMTCT) of HIV-1 : the TEmAA ANRS 12109 Phase II Trial, Step 1 |
| Arrivé E., Blanche S., Chaix M.L., Nerrienet E., Rouzioux C., McIntyre J., Grey G., Coffié P., Kruy Sim L., Ekouévi D., Dabis F. | |
| 04:00-4:30 pm | Coffee break and poster viewing |
| 04:30 pm | Session 4 : Immunological development and host defences in neonates and childrenChairs : M. Morgado, P. Rossi |
| Keynote Lecture : Neonatal adaptation of the immune system P. Brandtzaeg (N) | |
| 05:00–5:45 pm | |
| 5:00 pm | Microtransfusion and viral exposure in uninfected infants born to HIV-infected women |
| Warning J., Ziegler J., French R. | |
| 5:15 pm | Frequency of HIV-specific CD8 T lymphocytes is inversely correlated to HIV DNA levels in untreated infected children |
| Buseyne F., Blanche S., Burgard M., Milliancourt C., Scott_Algara D., Rouzioux C., Rivière Y. | |
| 5:30 pm | Primary CMV infection : a co-factor for HIV-1 disease progression in African infants ? |
| Slyker J. | |
| EVENING | 6:15 Concert & Painting private show |
Saturday, December 15, 2007 | |
| 09:00 am | Session 5 : Diagnosis, monitoring and treatment of infected childrenChairs : E. Nerrienet, N. Ngo-Giang-Huong |
| Keynote Lecture : Natural history of vertically acquired HCV infection P.A. Tovo (I) | |
| 09:30-10:30 am | |
| 9:30 am | Early diagnosis of HIV-1 infection in newborns, in the context of prevention of mother-to-child transmission with HAART (Perinatal Cohort ANRS Co 01) |
| Avettand-Fenoel V., Chaix M.L., Blanche S., Burgard M., Warszawski J., Rouzioux C. | |
| 9:45 am | Early versus deferred highly active antiretroviral therapy in HIV infected infants : a European collaborative cohort study |
| Goetghebuer T., Haelterman E., Hainaut M., Warszawski J., Le Chenadec J., Dollfus C., Gibb D.M., Giaquinto C., Levy J. for the European Infant Collaboration Group | |
| 10:00 am | Once-a-day pediatric HAART with DDI+3TC+EFV in Burkina Faso. A phase II Trial (ANRS 12103 trial) |
| Msellati P., Nacro B., Nicolas J., Mathieu O., Peyrière H., Yaméogo S., Drabo A., Ouiminga A., Diagbouga S., Rouet F., Tamboura H., Hien H., Zoure E., Van de Perre P. | |
| 10:15 am | Early virological suppression despite high frequency NNRTI resistance following perinatal prophylaxis in HIV-infected African infants |
| Prendergast A., Mphatswe W., Tudor-Williams G., Blanckenberg N., Cengimbo A., Jeena P., Rakgotho M., Pillay V., Thobakgale C., Reddy S., Mncube Z., Vanderstok M., McCarthy N., Dong C., Coovadia H., Morris L., Walker B.D., Goulder P. | |
| 10:30 am | Virus phenotype variability during disease progression of HIV-1 infected children |
| Dispinseri S., Cavarelli M., Ripamonti C., Karlsson I., Antonsson L., Plebani A., Fenyo E.M., Scarlatti G. | |
| 10:30-11:00 am | Coffee break and poster viewing |
| 11:00 am | Closing ceremony
Chairs : S. Blanche, C. Rouzioux, |
| Concluding remarks : F. Barré-Sinoussi | |
| Memorial lecture : Main infections in the children in developing countries : reports and perspectives C. Courpotin (F) | |
| Welcome to the DDIC 2008 S. Blanche, C. Rouzioux | |
| 12:00 pm | Closing of the conference :G. Scarlatti, E. Menu |